search
Back to results

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Primary Purpose

Moderate-to-Severe Atopic Dermatitis

Status
Active
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Nemolizumab
Sponsored by
Galderma R&D
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Moderate-to-Severe Atopic Dermatitis

Eligibility Criteria

12 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Key Inclusion Criteria:

  1. Subjects who may benefit from study participation in the opinion of the investigator and had participated in a prior nemolizumab study for AD
  2. Female subjects of childbearing potential (ie, fertile, following menarche and until becoming post-menopausal unless permanently sterile) must agree either to be strictly abstinent throughout the study and for 12 weeks after the last study drug injection, or to use an effective and approved method of contraception throughout the study and for 12 weeks after the last study drug injection.

Key Exclusion Criteria:

  1. Subjects who, during their participation in a prior nemolizumab study, experienced an AE which in the opinion of the investigator could indicate that continued treatment with nemolizumab may present an unreasonable risk for the subject.
  2. Pregnant women, breastfeeding women, or women planning a pregnancy during the clinical study.
  3. Body weight < 30 kg
  4. Cutaneous infection within 1 week before the baseline visit, any infection requiring treatment with oral or parenteral antibiotics, antivirals, antiparasitics or antifungals within 2 weeks before the baseline visit, or any confirmed or suspected coronavirus disease (COVID)-19 infection within 2 weeks before the screening or baseline visit. Subjects may be rescreened once the infection has resolved. Resolution of COVID-19 infection can be confirmed by recovery assessment methods.
  5. History of hypersensitivity (including anaphylaxis) to an immunoglobulin product (plasma-derived or recombinant, eg, monoclonal antibody)
  6. Any clinically significant issue, based investigator judgement

Sites / Locations

  • Galderma Investigational Site 8749
  • Galderma Investigational Site 8893
  • Galderma Investigational Site 8866
  • Galderma Investigational Site 8808
  • Galderma Investigational Site 8873
  • Galderma Investigational Site 8447
  • Galderma Investigational Site 8880
  • Galderma Investigational Site 8831
  • Galderma Investigational Site 8906
  • Galderma Investigational Site 8456
  • Galderma Investigational Site 8578
  • Galderma Investigational Site 8577
  • Galderma Investigational Site 8636
  • Galderma Investigational Site 8224
  • Galderma Investigational Site 8791
  • Galderma Investigational Site 8888
  • Galderma Investigational Site 8845
  • Galderma Investigational Site 8833
  • Galderma Investigational Site 8686
  • Galderma Investigational Site 8674
  • Galderma Investigational Site 8683
  • Galderma Investigational Site 8813
  • Galderma Investigational Site 8907
  • Galderma Investigational Site 8799
  • Galderma Investigational Site 8745
  • Galderma Investigational Site 8671
  • Galderma Investigational Site 8692
  • Galderma Investigational Site 8658
  • Galderma Investigational Site 8125
  • Galderma Investigational Site 8536
  • Galderma Investigational Site 8608
  • Galderma Investigational Site 8820
  • Galderma Investigational Site 8637
  • Galderma Investigational Site 8870
  • Galderma Investigational Site 8805
  • Galderma Investigational Site 8786
  • Galderma Investigational Site 8902
  • Galderma Investigational Site 8391
  • Galderma Investigational Site 8804
  • Galderma Investigational Site 8711
  • Galderma Investigational Site 8836
  • Galderma Investigational Site 8523
  • Galderma Investigational Site 8850
  • Galderma Investigational Site 8806
  • Galderma Investigational Site 8800
  • Galderma Investigational Site 8719
  • Galderma Investigational Site 8851
  • Galderma Investigational Site 8656
  • Galderma Investigational Site 8801
  • Galderma Investigational Site 8704
  • Galderma Investigational Site 8737
  • Galderma Investigational Site 8706
  • Galderma Investigational Site 8708
  • Galderma Investigational Site 8856
  • Galderma Investigational Site 8734
  • Galderma Investigational Site 8203
  • Galderma Investigational Site 8816
  • Galderma Investigational Site 8889
  • Galderma Investigational Site 8839
  • Galderma Investigational Site 8126
  • Galderma Investigational Site 8667
  • Galderma Investigational Site 8744
  • Galderma Investigational Site 8728
  • Galderma Investigational Site 8707
  • Galderma Investigational Site 8819
  • Galderma Investigational Site 9916
  • Galderma Investigational Site 8739
  • Galderma Investigational Site 8729
  • Galderma Investigational Sites 8571
  • Galderma Investigational Site 8712
  • Galderma Investigational Site 8142
  • Galderma Investigational Site 8724
  • Galderma Investigational Site 9934
  • Galderma Investigational Site 8771
  • Galderma Investigational Site 8882
  • Galderma Investigational Site 8743
  • Galderma Investigational Site 8512
  • Galderma Investigational Site 8554
  • Galderma Investigational Site 8617
  • Galderma Investigational Site 8155
  • Galderma Investigational Site 8849
  • Galderma Investigational Site 8226
  • Galderma Investigational Site 8748
  • Galderma Investigational Site 8521
  • Galderma Investigational Site 8718
  • Galderma Investigational Site 8810
  • Galderma Investigational Site 8740
  • Galderma Investigational Site 8825
  • Galderma Investigational Site 8675
  • Galderma Investigational Site 8109
  • Galderma Investigational Site 8506
  • Galderma Investigational Site 8826
  • Galderma Investigational Site 8242
  • Galderma Investigational Site 8741
  • Galderma Investigational Site 8723
  • Galderma Investigational Site 8828
  • Galderma Investigational Site 9925
  • Galderma Investigational Site 8733
  • Galderma Investigational Site 8620
  • Galderma Investigational Site 8279
  • Galderma Investigational Site 8772
  • Galderma Investigational Site 8795
  • Galderma Investigational Site 8726
  • Galderma Investigational Site 8648
  • Galderma Investigational Site 8702
  • Galderma Investigational Site 8747
  • Galderma Investigational Site 8595
  • Galderma Investigational Site 8206
  • Galderma Investigational Site 8857
  • Galderma Investigational Site 8212
  • Galderma Investigational Site 8255
  • Galderma Investigational Site 8721
  • Galderma Investigational Site 8802
  • Galderma Investigational Site 8777
  • Galderma Investigational Site 8736
  • Galderma Investigational Site 8713
  • Galderma Investigational Site 8818
  • Galderma Investigational Site 8133
  • Galderma Investigational Site 8298
  • Galderma Investigational Site 8238
  • Galderma Investigational Site 8245
  • Galderma Investigational Site 8827
  • Galderma Investigational Site 8664
  • Galderma Investigational Site 8807
  • Galderma Investigational Site 8042
  • Galderma Investigational Site 8670
  • Galderma Investigational Site 8817
  • Galderma Investigational Site 8787
  • Galderma Investigational Site 8329
  • Galderma Investigational Site 8618
  • Galderma Investigational Site 8003
  • Galderma Investigational Site 8672
  • Galderma Investigational Site 8738
  • Galderma Investigational Site 8862
  • Galderma Investigational Site 8896
  • Galderma Investigational Site 8434
  • Galderma Investigational Site 5441
  • Galderma Investigational Site 5759
  • Galderma Investigational Site 6152
  • Galderma Investigational Site 5638
  • Galderma Investigational Site 6161
  • Galderma Investigational Site 6159
  • Galderma Investigational Site 6131
  • Galderma Investigational Site 5366
  • Galderma Investigational Site 5458
  • Galderma Investigational Site 6160
  • Galderma Investigational Site 6153
  • Galderma Investigational Site 6156
  • Galderma Investigational Site 6157
  • Galderma Investigational Site 6194
  • Galderma Investigational Site 6158
  • Galderma Investigational Site 6038
  • Galderma Investigational Site 5448
  • Galderma Investigational Site 6163
  • Galderma Investigational Site 6164
  • Galderma Investigational Site 6162
  • Galderma Investigational Site 6029
  • Galderma Investigational Site 6051
  • Galderma Investigational Site 6078
  • Galderma Investigational Site 6102
  • Galderma Investigational Site 6165
  • Galderma Investigational Site 6216
  • Galderma Investigational Site 6046
  • Galderma Investigational Site 6080
  • Galderma Investigational Site 6101
  • Galderma Investigational Site 6079
  • Galderma Investigational Site 6250
  • Galderma Investigational Site 6136
  • Galderma Investigational Site 6251
  • Galderma Investigational Site 8085
  • Galderma Investigational Site 8903
  • Galderma Investigational Site 8215
  • Galderma Investigational Site 8824
  • Galderma Investigational Site 8722
  • Galderma Investigational Site 8161
  • Galderma Investigational Site 8586
  • Galderma Investigational Site 8904
  • Galderma Investigational Site 8780
  • Galderma Investigational Site 8610
  • Galderma Investigational Site 8901
  • Galderma Investigational Site 8336
  • Galderma Investigational Site 8899
  • Galderma Investigational Site 8731
  • Galderma Investigational Site 8000
  • Galderma Investigational Site 6055
  • Galderma Investigational Site 5225
  • Galderma Investigational Site 6030
  • Galderma Investigational Site 6024
  • Galderma Investigational Site 6240
  • Galderma Investigational Site 6021
  • Galderma Investigational Site 6054
  • Galderma Investigational Site 6025
  • Galderma Investigational Site 6068
  • Galderma Investigational Site 6069
  • Galderma Investigational Site 6067
  • Galderma Investigational Site 6198
  • Galderma Investigational Site 5031
  • Galderma Investigational Site 6170
  • Galderma Investigational Site 6167
  • Galderma Investigational Site 5140
  • Galderma Investigational Site 6133
  • Galderma Investigational Site 6166
  • Galderma Investigational Site 5407
  • Galderma Investigational Site 6135
  • Galderma Investigational Site 6197
  • Galderma Investigational Site 6169
  • Galderma Investigational Site 6168
  • Galderma Investigational Site 6224
  • Galderma Investigational Site 6228
  • Galderma Investigational Site 6235
  • Galderma Investigational Site 6238
  • Galderma Investigational Site 6227
  • Galderma Investigational Site 6230
  • Galderma Investigational Site 6234
  • Galderma Investigational Site 6236
  • Galderma Investigational Site 5482
  • Galderma Investigational Site 5566
  • Galderma Investigational Site 6022
  • Galderma Investigational Site 6110
  • Galderma Investigational Site 6061
  • Galderma Investigational Site 6082
  • Galderma Investigational Site 6062
  • Galderma Investigational Site 5368
  • Galderma Investigational Site 6132
  • Galderma Investigational Site 6028
  • Galderma Investigational Site 6031
  • Galderma Investigational Site 5442
  • Galderma Investigational Site 6081
  • Galderma Investigational Site 6062
  • Galderma Investigational Site 6041
  • Galderma Investigational Site 6150
  • Galderma Investigational Site 6040
  • Galderma Investigational Site 5469
  • Galderma Investigational Site 6086
  • Galderma Investigational Site 6146
  • Galderma Investigational Site 6084
  • Galderma Investigational Site 5382
  • Galderma Investigational Site 6039
  • Galderma Investigational Site 5918
  • Galderma Investigational Site 6109
  • Galderma Investigational Site 6214
  • Galderma Investigational Site 6147
  • Galderma Investigational Site 5513
  • Galderma Investigational Site 5567
  • Galderma Investigational Site 6026
  • Galderma Investigational Site 6254
  • Galderma Investigational Site 6053
  • Galderma Investigational Site 6145
  • Galderma Investigational Site 6045
  • Galderma Investigational Site 6049
  • Galderma Investigational Site 6177
  • Galderma Investigational Site 6155
  • Galderma Investigational Site 6175
  • Galderma Investigational Site 6095
  • Galderma Investigational Site 6100
  • Galderma Investigational Site 6098
  • Galderma Investigational Site 6154
  • Galderma Investigational Site 6138
  • Galderma Investigational Site 6120
  • Galderma Investigational Site 6093
  • Galderma Investigational Site 6105
  • Galderma Investigational Site 5659
  • Galderma Investigational Site 6116
  • Galderma Investigational Site 6129
  • Galderma Investigational Site 6103
  • Galderma Investigational Site 6056
  • Galderma Investigational Site 6094
  • Galderma Investigational Site 6099
  • Galderma Investigational Site 6113
  • Galderma Investigational Site 6134
  • Galderma Investigational Site 6059
  • Galderma Investigational Site 6060
  • Galderma Investigational Site 6111
  • Galderma Investigational Site 6073
  • Galderma Investigational Site 6112
  • Galderma Investigational Site 6212
  • Galderma Investigational Site 6108
  • Galderma Investigational Site 6027
  • Galderma Investigational Site 6119
  • Galderma Investigational Site 6118
  • Galderma Investigational Site 5773
  • Galderma Investigational Site 6097
  • Galderma Investigational Site 6255
  • Galderma Investigational Site 6075
  • Galderma Investigational Site 6243
  • Galderma Investigational Site 5138
  • Galderma Investigational Site 6244
  • Galderma Investigational Site 6087
  • Galderma Investigational Site 5021
  • Galderma Investigational Site 5362
  • Galderma Investigational Site 6052
  • Galderma Investigational Site 5367
  • Galderma Investigational Site 6071
  • Galderma Investigational Site 5377
  • Galderma Investigational Site 6063
  • Galderma Investigational Site 6237
  • Galderma Investigational Site 6085
  • Galderma Investigational Site 6127
  • Galderma Investigational Site 5495
  • Galderma Investigational Site 6088
  • Galderma Investigational Site 6223
  • Galderma Investigational Site 6130
  • Galderma Investigational Site 6048
  • Galderma Investigational Site 6126
  • Galderma Investigational Site 5707
  • Galderma Investigational Site 6065
  • Galderma Investigational Site 6122
  • Galderma Investigational Site 6242
  • Galderma Investigational Site 6064
  • Galderma Investigational Site 6222
  • Galderma Investigational Site 6047
  • Galderma Investigational Site 6185
  • Galderma Investigational Site 6096
  • Galderma Investigational Site 5005
  • Galderma Investigational Site 6245
  • Galderma Investigational Site 5570
  • Galderma Investigational Site 5363
  • Galderma Investigational Site 6231
  • Galderma Investigational Site 6124
  • Galderma Investigational Site 6077
  • Galderma Investigational Site 5499
  • Galderma Investigational Site 6057
  • Galderma Investigational Site 6037
  • Galderma Investigational Site 6035
  • Galderma Investigational Site 5580
  • Galderma Investigational Site 6106
  • Galderma Investigational Site 6058
  • Galderma Investigational Site 5842
  • Galderma Investigational Site 6190
  • Galderma Investigational Site 6186
  • Galderma Investigational Site 6036
  • Galderma Investigational Site 5551
  • Galderma Investigational Site 6191
  • Galderma Investigational Site 6202
  • Galderma Investigational Site 6207
  • Galderma Investigational Site 6203
  • Galderma Investigational Site 6090
  • Galderma Investigational Site 6104
  • Galderma Investigational Site 6204
  • Galderma Investigational Site 6121
  • Galderma Investigational Site 6205
  • Galderma Investigational Site 6208
  • Galderma Investigational Site 6206

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Nemolizumab

Arm Description

Nemolizumab administered via subcutaneous injection

Outcomes

Primary Outcome Measures

Incidence and Severity of TEAEs
Incidence of Serious TEAEs
Incidence and Severity of Adverse Events of Special Interest (AESIs) Throughout the Study

Secondary Outcome Measures

Proportion of Participants with IGA score = 0-1 at Each Visit
Proportion of Participants with EASI-75 at Each Visit
Change and Percent Change From Baseline in Overall Eczema Area and Severity Index (EASI) Score at Each Visit
EASI assesses severity and extent of AD signs through a composite score of erythema, induration/population, excoriation, and lichenification. The severity will be assessed on a scale of 0 (absent) to 3 (severe) for each of the 4 body areas: head/neck, trunk, upper limbs, and lower limbs, with half points allowed. The EASI score can range from 0 to 72 with higher scores representing greater severity of atopic dermatitis.
Proportion of Participants with IGA ≤ 2 at Each Visit
Change and Percent Change From Baseline in SCORAD Score at Each Visit
Change and Percent Change From Baseline in Participant-Reported Pruritus Using 10-cm VAS (SCORAD Sub-Component)
Change and Percent Change From Baseline in Participant-Reported Sleep Loss Using 10-cm VAS (SCORAD Sub-Component)
Proportion of Participants Reporting Low Disease Activity State Based on PGAD at Each Visit
Proportion of Participants Satisfied with Study Treatment Based on PGAT at each visit
Change from Baseline in Dermatology Life Quality Index (DLQI)
Change From Baseline in Children's Dermatology Life Quality Index (cDLQI) Total Score at Each Visit Through Week 200
Change From Baseline in Patient-Oriented Eczema Measure (POEM) Total Score at Each Visit Through Week 200
Change From Baseline in Hospital Anxiety and Depression Scale (HADS) for Each Subscale at Each Visit Through Week 200
Change From Baseline in Work Productivity and Activity Impairment: Atopic Dermatitis (WPAI:AD) for Each Subscale at Each Visit Through Week 200
Change From Baseline in EuroQoL 5-Dimension (EQ-5D) at Each Visit Through Week 200
Proportion of Participants Receiving Any Rescue Therapy by Rescue Treatment Type at Any Visit During the Treatment Period
Time to First Relapse
Duration of Remission
Time to Permanent Study Drug Discontinuation

Full Information

First Posted
June 14, 2019
Last Updated
September 25, 2023
Sponsor
Galderma R&D
search

1. Study Identification

Unique Protocol Identification Number
NCT03989206
Brief Title
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Official Title
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Moderate-to-Severe Atopic Dermatitis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 30, 2019 (Actual)
Primary Completion Date
August 31, 2026 (Anticipated)
Study Completion Date
August 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Galderma R&D

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Detailed Description
Long-term study to assess the safety and efficacy of nemolizumab in subjects with moderate-to-severe AD

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Moderate-to-Severe Atopic Dermatitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1700 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Nemolizumab
Arm Type
Experimental
Arm Description
Nemolizumab administered via subcutaneous injection
Intervention Type
Drug
Intervention Name(s)
Nemolizumab
Other Intervention Name(s)
CD14152
Intervention Description
Nemolizumab
Primary Outcome Measure Information:
Title
Incidence and Severity of TEAEs
Time Frame
Baseline to Week 200
Title
Incidence of Serious TEAEs
Time Frame
Baseline to Week 200
Title
Incidence and Severity of Adverse Events of Special Interest (AESIs) Throughout the Study
Time Frame
Baseline to Week 200
Secondary Outcome Measure Information:
Title
Proportion of Participants with IGA score = 0-1 at Each Visit
Time Frame
Baseline to Week 200
Title
Proportion of Participants with EASI-75 at Each Visit
Time Frame
Baseline to Week 200
Title
Change and Percent Change From Baseline in Overall Eczema Area and Severity Index (EASI) Score at Each Visit
Description
EASI assesses severity and extent of AD signs through a composite score of erythema, induration/population, excoriation, and lichenification. The severity will be assessed on a scale of 0 (absent) to 3 (severe) for each of the 4 body areas: head/neck, trunk, upper limbs, and lower limbs, with half points allowed. The EASI score can range from 0 to 72 with higher scores representing greater severity of atopic dermatitis.
Time Frame
Baseline to Week 200
Title
Proportion of Participants with IGA ≤ 2 at Each Visit
Time Frame
Baseline to Week 200
Title
Change and Percent Change From Baseline in SCORAD Score at Each Visit
Time Frame
Baseline to Week 200
Title
Change and Percent Change From Baseline in Participant-Reported Pruritus Using 10-cm VAS (SCORAD Sub-Component)
Time Frame
Baseline to Week 200
Title
Change and Percent Change From Baseline in Participant-Reported Sleep Loss Using 10-cm VAS (SCORAD Sub-Component)
Time Frame
Baseline to Week 200
Title
Proportion of Participants Reporting Low Disease Activity State Based on PGAD at Each Visit
Time Frame
Baseline to Week 200
Title
Proportion of Participants Satisfied with Study Treatment Based on PGAT at each visit
Time Frame
Baseline to Week 200
Title
Change from Baseline in Dermatology Life Quality Index (DLQI)
Time Frame
Baseline to Week 200
Title
Change From Baseline in Children's Dermatology Life Quality Index (cDLQI) Total Score at Each Visit Through Week 200
Time Frame
Baseline to Week 200
Title
Change From Baseline in Patient-Oriented Eczema Measure (POEM) Total Score at Each Visit Through Week 200
Time Frame
Baseline to Week 200
Title
Change From Baseline in Hospital Anxiety and Depression Scale (HADS) for Each Subscale at Each Visit Through Week 200
Time Frame
Baseline to Week 200
Title
Change From Baseline in Work Productivity and Activity Impairment: Atopic Dermatitis (WPAI:AD) for Each Subscale at Each Visit Through Week 200
Time Frame
Baseline to Week 200
Title
Change From Baseline in EuroQoL 5-Dimension (EQ-5D) at Each Visit Through Week 200
Time Frame
Baseline to Week 200
Title
Proportion of Participants Receiving Any Rescue Therapy by Rescue Treatment Type at Any Visit During the Treatment Period
Time Frame
Baseline to Week 200
Title
Time to First Relapse
Time Frame
Baseline to Week 200
Title
Duration of Remission
Time Frame
Baseline to Week 200
Title
Time to Permanent Study Drug Discontinuation
Time Frame
Baseline to Week 200

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Key Inclusion Criteria: Subjects who may benefit from study participation in the opinion of the investigator and had participated in a prior nemolizumab study for AD Female subjects of childbearing potential (ie, fertile, following menarche and until becoming post-menopausal unless permanently sterile) must agree either to be strictly abstinent throughout the study and for 12 weeks after the last study drug injection, or to use an effective and approved method of contraception throughout the study and for 12 weeks after the last study drug injection. Key Exclusion Criteria: Subjects who, during their participation in a prior nemolizumab study, experienced an AE which in the opinion of the investigator could indicate that continued treatment with nemolizumab may present an unreasonable risk for the subject. Pregnant women, breastfeeding women, or women planning a pregnancy during the clinical study. Body weight < 30 kg Cutaneous infection within 1 week before the baseline visit, any infection requiring treatment with oral or parenteral antibiotics, antivirals, antiparasitics or antifungals within 2 weeks before the baseline visit, or any confirmed or suspected coronavirus disease (COVID)-19 infection within 2 weeks before the screening or baseline visit. Subjects may be rescreened once the infection has resolved. Resolution of COVID-19 infection can be confirmed by recovery assessment methods. History of hypersensitivity (including anaphylaxis) to an immunoglobulin product (plasma-derived or recombinant, eg, monoclonal antibody) Any clinically significant issue, based investigator judgement
Facility Information:
Facility Name
Galderma Investigational Site 8749
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35244
Country
United States
Facility Name
Galderma Investigational Site 8893
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35244
Country
United States
Facility Name
Galderma Investigational Site 8866
City
Guntersville
State/Province
Alabama
ZIP/Postal Code
35976
Country
United States
Facility Name
Galderma Investigational Site 8808
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85255
Country
United States
Facility Name
Galderma Investigational Site 8873
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85260
Country
United States
Facility Name
Galderma Investigational Site 8447
City
Fort Smith
State/Province
Arkansas
ZIP/Postal Code
72916
Country
United States
Facility Name
Galderma Investigational Site 8880
City
North Little Rock
State/Province
Arkansas
ZIP/Postal Code
72117
Country
United States
Facility Name
Galderma Investigational Site 8831
City
Anaheim
State/Province
California
ZIP/Postal Code
92801
Country
United States
Facility Name
Galderma Investigational Site 8906
City
Bell Gardens
State/Province
California
ZIP/Postal Code
90201
Country
United States
Facility Name
Galderma Investigational Site 8456
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90212
Country
United States
Facility Name
Galderma Investigational Site 8578
City
Cerritos
State/Province
California
ZIP/Postal Code
90703
Country
United States
Facility Name
Galderma Investigational Site 8577
City
Encinitas
State/Province
California
ZIP/Postal Code
92024
Country
United States
Facility Name
Galderma Investigational Site 8636
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Facility Name
Galderma Investigational Site 8224
City
Fremont
State/Province
California
ZIP/Postal Code
94538
Country
United States
Facility Name
Galderma Investigational Site 8791
City
Fresno
State/Province
California
ZIP/Postal Code
93720
Country
United States
Facility Name
Galderma Investigational Site 8888
City
Fullerton
State/Province
California
ZIP/Postal Code
92835
Country
United States
Facility Name
Galderma Investigational Site 8845
City
Huntington Beach
State/Province
California
ZIP/Postal Code
92647
Country
United States
Facility Name
Galderma Investigational Site 8833
City
Inglewood
State/Province
California
ZIP/Postal Code
90301
Country
United States
Facility Name
Galderma Investigational Site 8686
City
Lomita
State/Province
California
ZIP/Postal Code
90717
Country
United States
Facility Name
Galderma Investigational Site 8674
City
Los Angeles
State/Province
California
ZIP/Postal Code
90025
Country
United States
Facility Name
Galderma Investigational Site 8683
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Facility Name
Galderma Investigational Site 8813
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Facility Name
Galderma Investigational Site 8907
City
Newport Beach
State/Province
California
ZIP/Postal Code
92660
Country
United States
Facility Name
Galderma Investigational Site 8799
City
Ontario
State/Province
California
ZIP/Postal Code
91762
Country
United States
Facility Name
Galderma Investigational Site 8745
City
Pasadena
State/Province
California
ZIP/Postal Code
91105
Country
United States
Facility Name
Galderma Investigational Site 8671
City
San Diego
State/Province
California
ZIP/Postal Code
92108
Country
United States
Facility Name
Galderma Investigational Site 8692
City
San Diego
State/Province
California
ZIP/Postal Code
92121
Country
United States
Facility Name
Galderma Investigational Site 8658
City
San Diego
State/Province
California
ZIP/Postal Code
92123
Country
United States
Facility Name
Galderma Investigational Site 8125
City
San Francisco
State/Province
California
ZIP/Postal Code
94115
Country
United States
Facility Name
Galderma Investigational Site 8536
City
Santa Ana
State/Province
California
ZIP/Postal Code
92705
Country
United States
Facility Name
Galderma Investigational Site 8608
City
Santa Monica
State/Province
California
ZIP/Postal Code
90404
Country
United States
Facility Name
Galderma Investigational Site 8820
City
Westminster
State/Province
California
ZIP/Postal Code
92683
Country
United States
Facility Name
Galderma Investigational Site 8637
City
Farmington
State/Province
Connecticut
ZIP/Postal Code
06606
Country
United States
Facility Name
Galderma Investigational Site 8870
City
Boca Raton
State/Province
Florida
ZIP/Postal Code
33433
Country
United States
Facility Name
Galderma Investigational Site 8805
City
Cape Coral
State/Province
Florida
ZIP/Postal Code
33991
Country
United States
Facility Name
Galderma Investigational Site 8786
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765
Country
United States
Facility Name
Galderma Investigational Site 8902
City
Doral
State/Province
Florida
ZIP/Postal Code
33122
Country
United States
Facility Name
Galderma Investigational Site 8391
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Galderma Investigational Site 8804
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Galderma Investigational Site 8711
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32256
Country
United States
Facility Name
Galderma Investigational Site 8836
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32256
Country
United States
Facility Name
Galderma Investigational Site 8523
City
Largo
State/Province
Florida
ZIP/Postal Code
33770
Country
United States
Facility Name
Galderma Investigational Site 8850
City
Margate
State/Province
Florida
ZIP/Postal Code
33063
Country
United States
Facility Name
Galderma Investigational Site 8806
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Facility Name
Galderma Investigational Site 8800
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Galderma Investigational Site 8719
City
Miami
State/Province
Florida
ZIP/Postal Code
33125
Country
United States
Facility Name
Galderma Investigational Site 8851
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Facility Name
Galderma Investigational Site 8656
City
Miami
State/Province
Florida
ZIP/Postal Code
33137
Country
United States
Facility Name
Galderma Investigational Site 8801
City
Miami
State/Province
Florida
ZIP/Postal Code
33145
Country
United States
Facility Name
Galderma Investigational Site 8704
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Facility Name
Galderma Investigational Site 8737
City
Miami
State/Province
Florida
ZIP/Postal Code
33174
Country
United States
Facility Name
Galderma Investigational Site 8706
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Facility Name
Galderma Investigational Site 8708
City
Miami
State/Province
Florida
ZIP/Postal Code
33176
Country
United States
Facility Name
Galderma Investigational Site 8856
City
Ormond Beach
State/Province
Florida
ZIP/Postal Code
33174
Country
United States
Facility Name
Galderma Investigational Site 8734
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33028
Country
United States
Facility Name
Galderma Investigational Site 8203
City
Tampa
State/Province
Florida
ZIP/Postal Code
33607
Country
United States
Facility Name
Galderma Investigational Site 8816
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613
Country
United States
Facility Name
Galderma Investigational Site 8889
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613
Country
United States
Facility Name
Galderma Investigational Site 8839
City
Tampa
State/Province
Florida
ZIP/Postal Code
33615
Country
United States
Facility Name
Galderma Investigational Site 8126
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33401
Country
United States
Facility Name
Galderma Investigational Site 8667
City
Columbus
State/Province
Georgia
ZIP/Postal Code
31904
Country
United States
Facility Name
Galderma Investigational Site 8744
City
Macon
State/Province
Georgia
ZIP/Postal Code
31217
Country
United States
Facility Name
Galderma Investigational Site 8728
City
Newnan
State/Province
Georgia
ZIP/Postal Code
30263
Country
United States
Facility Name
Galderma Investigational Site 8707
City
Stockbridge
State/Province
Georgia
ZIP/Postal Code
30281
Country
United States
Facility Name
Galderma Investigational Site 8819
City
Nampa
State/Province
Idaho
ZIP/Postal Code
83687
Country
United States
Facility Name
Galderma Investigational Site 9916
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Facility Name
Galderma Investigational Site 8739
City
Normal
State/Province
Illinois
ZIP/Postal Code
61761
Country
United States
Facility Name
Galderma Investigational Site 8729
City
Rolling Meadows
State/Province
Illinois
ZIP/Postal Code
60008
Country
United States
Facility Name
Galderma Investigational Sites 8571
City
Skokie
State/Province
Illinois
ZIP/Postal Code
60076
Country
United States
Facility Name
Galderma Investigational Site 8712
City
Skokie
State/Province
Illinois
ZIP/Postal Code
60077
Country
United States
Facility Name
Galderma Investigational Site 8142
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46250
Country
United States
Facility Name
Galderma Investigational Site 8724
City
New Albany
State/Province
Indiana
ZIP/Postal Code
47150
Country
United States
Facility Name
Galderma Investigational Site 9934
City
Shawnee Mission
State/Province
Kansas
ZIP/Postal Code
66216
Country
United States
Facility Name
Galderma Investigational Site 8771
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40241-6162
Country
United States
Facility Name
Galderma Investigational Site 8882
City
Bangor
State/Province
Maine
ZIP/Postal Code
04401
Country
United States
Facility Name
Galderma Investigational Site 8743
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
Facility Name
Galderma Investigational Site 8512
City
Bay City
State/Province
Michigan
ZIP/Postal Code
48706
Country
United States
Facility Name
Galderma Investigational Site 8554
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
Facility Name
Galderma Investigational Site 8617
City
Farmington Hills
State/Province
Michigan
ZIP/Postal Code
48334
Country
United States
Facility Name
Galderma Investigational Site 8155
City
Troy
State/Province
Michigan
ZIP/Postal Code
48084
Country
United States
Facility Name
Galderma Investigational Site 8849
City
Troy
State/Province
Michigan
ZIP/Postal Code
48084
Country
United States
Facility Name
Galderma Investigational Site 8226
City
Warren
State/Province
Michigan
ZIP/Postal Code
48088
Country
United States
Facility Name
Galderma Investigational Site 8748
City
Ypsilanti
State/Province
Michigan
ZIP/Postal Code
48197
Country
United States
Facility Name
Galderma Investigational Site 8521
City
Saint Joseph
State/Province
Missouri
ZIP/Postal Code
64506
Country
United States
Facility Name
Galderma Investigational Site 8718
City
Missoula
State/Province
Montana
ZIP/Postal Code
59808
Country
United States
Facility Name
Galderma Investigational Site 8810
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68144
Country
United States
Facility Name
Galderma Investigational Site 8740
City
Henderson
State/Province
Nevada
ZIP/Postal Code
89002
Country
United States
Facility Name
Galderma Investigational Site 8825
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89106
Country
United States
Facility Name
Galderma Investigational Site 8675
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89119
Country
United States
Facility Name
Galderma Investigational Site 8109
City
Lebanon
State/Province
New Hampshire
ZIP/Postal Code
03766
Country
United States
Facility Name
Galderma Investigational Site 8506
City
Hackensack
State/Province
New Jersey
ZIP/Postal Code
07601
Country
United States
Facility Name
Galderma Investigational Site 8826
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87106
Country
United States
Facility Name
Galderma Investigational Site 8242
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11203
Country
United States
Facility Name
Galderma Investigational Site 8741
City
Buffalo
State/Province
New York
ZIP/Postal Code
14221
Country
United States
Facility Name
Galderma Investigational Site 8723
City
Cortland
State/Province
New York
ZIP/Postal Code
13045
Country
United States
Facility Name
Galderma Investigational Site 8828
City
Forest Hills
State/Province
New York
ZIP/Postal Code
11375
Country
United States
Facility Name
Galderma Investigational Site 9925
City
Glendale
State/Province
New York
ZIP/Postal Code
11385
Country
United States
Facility Name
Galderma Investigational Site 8733
City
New York
State/Province
New York
ZIP/Postal Code
10022
Country
United States
Facility Name
Galderma Investigational Site 8620
City
New York
State/Province
New York
ZIP/Postal Code
10023
Country
United States
Facility Name
Galderma Investigational Site 8279
City
New York
State/Province
New York
ZIP/Postal Code
10075
Country
United States
Facility Name
Galderma Investigational Site 8772
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States
Facility Name
Galderma Investigational Site 8795
City
Shelby
State/Province
North Carolina
ZIP/Postal Code
28150
Country
United States
Facility Name
Galderma Investigational Site 8726
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28405-3176
Country
United States
Facility Name
Galderma Investigational Site 8648
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28405
Country
United States
Facility Name
Galderma Investigational Site 8702
City
Bexley
State/Province
Ohio
ZIP/Postal Code
43209
Country
United States
Facility Name
Galderma Investigational Site 8747
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
Facility Name
Galderma Investigational Site 8595
City
Dublin
State/Province
Ohio
ZIP/Postal Code
43016
Country
United States
Facility Name
Galderma Investigational Site 8206
City
Norman
State/Province
Oklahoma
ZIP/Postal Code
73071
Country
United States
Facility Name
Galderma Investigational Site 8857
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73118
Country
United States
Facility Name
Galderma Investigational Site 8212
City
Portland
State/Province
Oregon
ZIP/Postal Code
97210
Country
United States
Facility Name
Galderma Investigational Site 8255
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19103
Country
United States
Facility Name
Galderma Investigational Site 8721
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Name
Galderma Investigational Site 8802
City
Plymouth Meeting
State/Province
Pennsylvania
ZIP/Postal Code
19462
Country
United States
Facility Name
Galderma Investigational Site 8777
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29407
Country
United States
Facility Name
Galderma Investigational Site 8736
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Facility Name
Galderma Investigational Site 8713
City
North Charleston
State/Province
South Carolina
ZIP/Postal Code
29420
Country
United States
Facility Name
Galderma Investigational Site 8818
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57702
Country
United States
Facility Name
Galderma Investigational Site 8133
City
Arlington
State/Province
Texas
ZIP/Postal Code
76011
Country
United States
Facility Name
Galderma Investigational Site 8298
City
Austin
State/Province
Texas
ZIP/Postal Code
78723
Country
United States
Facility Name
Galderma Investigational Site 8238
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
Facility Name
Galderma Investigational Site 8245
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Facility Name
Galderma Investigational Site 8827
City
Dripping Springs
State/Province
Texas
ZIP/Postal Code
78620
Country
United States
Facility Name
Galderma Investigational Site 8664
City
Frisco
State/Province
Texas
ZIP/Postal Code
75034
Country
United States
Facility Name
Galderma Investigational Site 8807
City
Houston
State/Province
Texas
ZIP/Postal Code
77029
Country
United States
Facility Name
Galderma Investigational Site 8042
City
Houston
State/Province
Texas
ZIP/Postal Code
77056
Country
United States
Facility Name
Galderma Investigational Site 8670
City
Houston
State/Province
Texas
ZIP/Postal Code
77401
Country
United States
Facility Name
Galderma Investigational Site 8817
City
Katy
State/Province
Texas
ZIP/Postal Code
77494
Country
United States
Facility Name
Galderma Investigational Site 8787
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Facility Name
Galderma Investigational Site 8329
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Galderma Investigational Site 8618
City
Waco
State/Province
Texas
ZIP/Postal Code
76710
Country
United States
Facility Name
Galderma Investigational Site 8003
City
Webster
State/Province
Texas
ZIP/Postal Code
77598
Country
United States
Facility Name
Galderma Investigational Site 8672
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84117
Country
United States
Facility Name
Galderma Investigational Site 8738
City
Burke
State/Province
Virginia
ZIP/Postal Code
22015
Country
United States
Facility Name
Galderma Investigational Site 8862
City
Fairfax
State/Province
Virginia
ZIP/Postal Code
22031
Country
United States
Facility Name
Galderma Investigational Site 8896
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23219
Country
United States
Facility Name
Galderma Investigational Site 8434
City
Seattle
State/Province
Washington
ZIP/Postal Code
98105
Country
United States
Facility Name
Galderma Investigational Site 5441
City
Darlinghurst
State/Province
New South Wales
ZIP/Postal Code
2010
Country
Australia
Facility Name
Galderma Investigational Site 5759
City
Kogarah
State/Province
New South Wales
ZIP/Postal Code
2217
Country
Australia
Facility Name
Galderma Investigational Site 6152
City
Westmead
State/Province
New South Wales
ZIP/Postal Code
2145
Country
Australia
Facility Name
Galderma Investigational Site 5638
City
Benowa
State/Province
Queensland
ZIP/Postal Code
4217
Country
Australia
Facility Name
Galderma Investigational Site 6161
City
Brisbane
State/Province
Queensland
ZIP/Postal Code
4102
Country
Australia
Facility Name
Galderma Investigational Site 6159
City
Woodville
State/Province
South Australia
ZIP/Postal Code
5011
Country
Australia
Facility Name
Galderma Investigational Site 6131
City
Carlton
State/Province
Victoria
ZIP/Postal Code
3053
Country
Australia
Facility Name
Galderma Investigational Site 5366
City
East Melbourne
State/Province
Victoria
ZIP/Postal Code
3002
Country
Australia
Facility Name
Galderma Investigational Site 5458
City
Parkville
State/Province
Victoria
ZIP/Postal Code
3050
Country
Australia
Facility Name
Galderma Investigational Site 6160
City
Parkville
State/Province
Victoria
ZIP/Postal Code
3052
Country
Australia
Facility Name
Galderma Investigational Site 6153
City
Victoria Park
State/Province
Western Australia
ZIP/Postal Code
6100
Country
Australia
Facility Name
Galderma Investigational Site 6156
City
Linz
State/Province
Oberoesterreich
ZIP/Postal Code
4020
Country
Austria
Facility Name
Galderma Investigational Site 6157
City
Graz
State/Province
Styria
ZIP/Postal Code
8036
Country
Austria
Facility Name
Galderma Investigational Site 6194
City
Vienna
ZIP/Postal Code
1090
Country
Austria
Facility Name
Galderma Investigational Site 6158
City
Vienna
ZIP/Postal Code
1220
Country
Austria
Facility Name
Galderma Investigational Site 6038
City
Leuven
State/Province
Vlaams-Brabant
ZIP/Postal Code
3000
Country
Belgium
Facility Name
Galderma Investigational Site 5448
City
Brussels
ZIP/Postal Code
1200
Country
Belgium
Facility Name
Galderma Investigational Site 6163
City
Edegem
ZIP/Postal Code
2650
Country
Belgium
Facility Name
Galderma Investigational Site 6164
City
Gent
ZIP/Postal Code
9000
Country
Belgium
Facility Name
Galderma Investigational Site 6162
City
Liège
ZIP/Postal Code
4000
Country
Belgium
Facility Name
Galderma Investigational Site 6029
City
Pleven
ZIP/Postal Code
5800
Country
Bulgaria
Facility Name
Galderma Investigational Site 6051
City
Sofia
ZIP/Postal Code
1407
Country
Bulgaria
Facility Name
Galderma Investigational Site 6078
City
Sofia
ZIP/Postal Code
1408
Country
Bulgaria
Facility Name
Galderma Investigational Site 6102
City
Sofia
ZIP/Postal Code
1431
Country
Bulgaria
Facility Name
Galderma Investigational Site 6165
City
Sofia
ZIP/Postal Code
1431
Country
Bulgaria
Facility Name
Galderma Investigational Site 6216
City
Sofia
ZIP/Postal Code
1528
Country
Bulgaria
Facility Name
Galderma Investigational Site 6046
City
Sofia
ZIP/Postal Code
1606
Country
Bulgaria
Facility Name
Galderma Investigational Site 6080
City
Sofia
ZIP/Postal Code
1606
Country
Bulgaria
Facility Name
Galderma Investigational Site 6101
City
Sofia
ZIP/Postal Code
1612
Country
Bulgaria
Facility Name
Galderma Investigational Site 6079
City
Sofia
ZIP/Postal Code
1618
Country
Bulgaria
Facility Name
Galderma Investigational Site 6250
City
Sofia
ZIP/Postal Code
1784
Country
Bulgaria
Facility Name
Galderma Investigational Site 6136
City
Stara Zagora
ZIP/Postal Code
6000
Country
Bulgaria
Facility Name
Galderma Investigational Site 6251
City
Stara Zagora
ZIP/Postal Code
6000
Country
Bulgaria
Facility Name
Galderma Investigational Site 8085
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2G 1B1
Country
Canada
Facility Name
Galderma Investigational Site 8903
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2J 7E1
Country
Canada
Facility Name
Galderma Investigational Site 8215
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T3E 0B2
Country
Canada
Facility Name
Galderma Investigational Site 8824
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 1C3
Country
Canada
Facility Name
Galderma Investigational Site 8722
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 1C9
Country
Canada
Facility Name
Galderma Investigational Site 8161
City
Surrey
State/Province
British Columbia
ZIP/Postal Code
V3V 0C6
Country
Canada
Facility Name
Galderma Investigational Site 8586
City
Barrie
State/Province
Ontario
ZIP/Postal Code
L4M 7G1
Country
Canada
Facility Name
Galderma Investigational Site 8904
City
Guelph
State/Province
Ontario
ZIP/Postal Code
N1L 0B7
Country
Canada
Facility Name
Galderma Investigational Site 8780
City
Niagara Falls
State/Province
Ontario
ZIP/Postal Code
L2H 1H5
Country
Canada
Facility Name
Galderma Investigational Site 8610
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1G 6C6
Country
Canada
Facility Name
Galderma Investigational Site 8901
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1H 7X3
Country
Canada
Facility Name
Galderma Investigational Site 8336
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M3H 5Y8
Country
Canada
Facility Name
Galderma Investigational Site 8899
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4W 2N4
Country
Canada
Facility Name
Galderma Investigational Site 8731
City
Waterloo
State/Province
Ontario
ZIP/Postal Code
N2J 1C4
Country
Canada
Facility Name
Galderma Investigational Site 8000
City
Saint John
ZIP/Postal Code
A1C 2H5
Country
Canada
Facility Name
Galderma Investigational Site 6055
City
Brno
ZIP/Postal Code
656 91
Country
Czechia
Facility Name
Galderma Investigational Site 5225
City
Náchod
ZIP/Postal Code
547 01
Country
Czechia
Facility Name
Galderma Investigational Site 6030
City
Olomouc
ZIP/Postal Code
779 00
Country
Czechia
Facility Name
Galderma Investigational Site 6024
City
Prague
ZIP/Postal Code
100 00
Country
Czechia
Facility Name
Galderma Investigational Site 6240
City
Prague
ZIP/Postal Code
120 00
Country
Czechia
Facility Name
Galderma Investigational Site 6021
City
Praha
ZIP/Postal Code
110 00
Country
Czechia
Facility Name
Galderma Investigational Site 6054
City
Praha
ZIP/Postal Code
110 00
Country
Czechia
Facility Name
Galderma Investigational Site 6025
City
Praha
ZIP/Postal Code
150 06
Country
Czechia
Facility Name
Galderma Investigational Site 6068
City
Tallinn
ZIP/Postal Code
10134
Country
Estonia
Facility Name
Galderma Investigational Site 6069
City
Tallinn
ZIP/Postal Code
10138
Country
Estonia
Facility Name
Galderma Investigational Site 6067
City
Tartu
ZIP/Postal Code
50417
Country
Estonia
Facility Name
Galderma Investigational Site 6198
City
Le Mans
ZIP/Postal Code
72037
Country
France
Facility Name
Galderma Investigational Site 5031
City
Lille
ZIP/Postal Code
59037
Country
France
Facility Name
Galderma Investigational Site 6170
City
Martigues
ZIP/Postal Code
13500
Country
France
Facility Name
Galderma Investigational Site 6167
City
Nantes
ZIP/Postal Code
44093
Country
France
Facility Name
Galderma Investigational Site 5140
City
Nice
ZIP/Postal Code
06200
Country
France
Facility Name
Galderma Investigational Site 6133
City
Paris
ZIP/Postal Code
75015
Country
France
Facility Name
Galderma Investigational Site 6166
City
Paris
ZIP/Postal Code
75475
Country
France
Facility Name
Galderma Investigational Site 5407
City
Pierre-Bénite
ZIP/Postal Code
69495
Country
France
Facility Name
Galderma Investigational Site 6135
City
Quimper
ZIP/Postal Code
29107
Country
France
Facility Name
Galderma Investigational Site 6197
City
Toulon
ZIP/Postal Code
83800
Country
France
Facility Name
Galderma Investigational Site 6169
City
Toulouse
ZIP/Postal Code
31000
Country
France
Facility Name
Galderma Investigational Site 6168
City
Valence
ZIP/Postal Code
26000
Country
France
Facility Name
Galderma Investigational Site 6224
City
Tbilisi
ZIP/Postal Code
0159
Country
Georgia
Facility Name
Galderma Investigational Site 6228
City
Tbilisi
ZIP/Postal Code
0159
Country
Georgia
Facility Name
Galderma Investigational Site 6235
City
Tbilisi
ZIP/Postal Code
0159
Country
Georgia
Facility Name
Galderma Investigational Site 6238
City
Tbilisi
ZIP/Postal Code
0159
Country
Georgia
Facility Name
Galderma Investigational Site 6227
City
Tbilisi
ZIP/Postal Code
0186
Country
Georgia
Facility Name
Galderma Investigational Site 6230
City
Tbilisi
ZIP/Postal Code
0186
Country
Georgia
Facility Name
Galderma Investigational Site 6234
City
Tbilisi
ZIP/Postal Code
0186
Country
Georgia
Facility Name
Galderma Investigational Site 6236
City
Zugdidi
ZIP/Postal Code
2100
Country
Georgia
Facility Name
Galderma Investigational Site 5482
City
Aachen
ZIP/Postal Code
52074
Country
Germany
Facility Name
Galderma Investigational Site 5566
City
Augsburg
ZIP/Postal Code
86179
Country
Germany
Facility Name
Galderma Investigational Site 6022
City
Bad Bentheim
ZIP/Postal Code
48455
Country
Germany
Facility Name
Galderma Investigational Site 6110
City
Berlin
ZIP/Postal Code
13055
Country
Germany
Facility Name
Galderma Investigational Site 6061
City
Bielefeld
ZIP/Postal Code
33647
Country
Germany
Facility Name
Galderma Investigational Site 6082
City
Bonn
ZIP/Postal Code
53127
Country
Germany
Facility Name
Galderma Investigational Site 6062
City
Buxtehude
ZIP/Postal Code
21614
Country
Germany
Facility Name
Galderma Investigational Site 5368
City
Darmstadt
ZIP/Postal Code
64283
Country
Germany
Facility Name
Galderma Investigational Site 6132
City
Dresden
ZIP/Postal Code
01097
Country
Germany
Facility Name
Galderma Investigational Site 6028
City
Dülmen
ZIP/Postal Code
48249
Country
Germany
Facility Name
Galderma Investigational Site 6031
City
Düsseldorf
ZIP/Postal Code
40225
Country
Germany
Facility Name
Galderma Investigational Site 5442
City
Gera
ZIP/Postal Code
07548
Country
Germany
Facility Name
Galderma Investigational Site 6081
City
Goettigen
ZIP/Postal Code
37075
Country
Germany
Facility Name
Galderma Investigational Site 6062
City
Halle
ZIP/Postal Code
06120
Country
Germany
Facility Name
Galderma Investigational Site 6041
City
Hamburg
ZIP/Postal Code
20251
Country
Germany
Facility Name
Galderma Investigational Site 6150
City
Hamburg
ZIP/Postal Code
20537
Country
Germany
Facility Name
Galderma Investigational Site 6040
City
Hamburg
ZIP/Postal Code
22391
Country
Germany
Facility Name
Galderma Investigational Site 5469
City
Heidelberg
ZIP/Postal Code
69120
Country
Germany
Facility Name
Galderma Investigational Site 6086
City
Kiel
ZIP/Postal Code
24148
Country
Germany
Facility Name
Galderma Investigational Site 6146
City
Langenau
ZIP/Postal Code
89129
Country
Germany
Facility Name
Galderma Investigational Site 6084
City
Mainz
ZIP/Postal Code
55131
Country
Germany
Facility Name
Galderma Investigational Site 5382
City
Munich
ZIP/Postal Code
80337
Country
Germany
Facility Name
Galderma Investigational Site 6039
City
Münster
ZIP/Postal Code
48149
Country
Germany
Facility Name
Galderma Investigational Site 5918
City
Osnabrück
ZIP/Postal Code
49074
Country
Germany
Facility Name
Galderma Investigational Site 6109
City
Stuttgart
ZIP/Postal Code
70499
Country
Germany
Facility Name
Galderma Investigational Site 6214
City
Tuebingen
ZIP/Postal Code
72076
Country
Germany
Facility Name
Galderma Investigational Site 6147
City
Budapest
ZIP/Postal Code
1036
Country
Hungary
Facility Name
Galderma Investigational Site 5513
City
Budapest
ZIP/Postal Code
1085
Country
Hungary
Facility Name
Galderma Investigational Site 5567
City
Debrecen
ZIP/Postal Code
4025
Country
Hungary
Facility Name
Galderma Investigational Site 6026
City
Debrecen
ZIP/Postal Code
4032
Country
Hungary
Facility Name
Galderma Investigational Site 6254
City
Gyula
ZIP/Postal Code
5700
Country
Hungary
Facility Name
Galderma Investigational Site 6053
City
Veszprem
ZIP/Postal Code
8200
Country
Hungary
Facility Name
Galderma Investigational Site 6145
City
Bologna
ZIP/Postal Code
40138
Country
Italy
Facility Name
Galderma Investigational Site 6045
City
L'Aquila
ZIP/Postal Code
67100
Country
Italy
Facility Name
Galderma Investigational Site 6049
City
Roma
ZIP/Postal Code
00168
Country
Italy
Facility Name
Galderma Investigational Site 6177
City
Rome
ZIP/Postal Code
00144
Country
Italy
Facility Name
Galderma Investigational Site 6155
City
Rozzano
ZIP/Postal Code
20089
Country
Italy
Facility Name
Galderma Investigational Site 6175
City
Vicenza
ZIP/Postal Code
36100
Country
Italy
Facility Name
Galderma Investigational Site 6095
City
Bucheon-Si
ZIP/Postal Code
14584
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6100
City
Busan
ZIP/Postal Code
49241
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6098
City
Gyeonggi-do
ZIP/Postal Code
15355
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6154
City
Gyeonggi-Do
ZIP/Postal Code
18450
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6138
City
Incheon
ZIP/Postal Code
21431
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6120
City
Incheon
ZIP/Postal Code
21565
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6093
City
Incheon
ZIP/Postal Code
22332
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6105
City
Seoul
ZIP/Postal Code
02841
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 5659
City
Seoul
ZIP/Postal Code
03080
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6116
City
Seoul
ZIP/Postal Code
03722
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6129
City
Seoul
ZIP/Postal Code
04763
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6103
City
Seoul
ZIP/Postal Code
05030
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6056
City
Seoul
ZIP/Postal Code
06591
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6094
City
Seoul
ZIP/Postal Code
06973
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6099
City
Seoul
ZIP/Postal Code
07441
Country
Korea, Republic of
Facility Name
Galderma Investigational Site 6113
City
Liepaja
ZIP/Postal Code
LV-3401
Country
Latvia
Facility Name
Galderma Investigational Site 6134
City
Riga
ZIP/Postal Code
LV-1006
Country
Latvia
Facility Name
Galderma Investigational Site 6059
City
Riga
ZIP/Postal Code
LV-1009
Country
Latvia
Facility Name
Galderma Investigational Site 6060
City
Talsi
ZIP/Postal Code
LV-3201
Country
Latvia
Facility Name
Galderma Investigational Site 6111
City
Kaunas
ZIP/Postal Code
LT-50161
Country
Lithuania
Facility Name
Galderma Investigational Site 6073
City
Vilnius
ZIP/Postal Code
LT-07195
Country
Lithuania
Facility Name
Galderma Investigational Site 6112
City
Vilnius
ZIP/Postal Code
LT-08411
Country
Lithuania
Facility Name
Galderma Investigational Site 6212
City
Groningen
ZIP/Postal Code
9713
Country
Netherlands
Facility Name
Galderma Investigational Site 6108
City
Rotterdam
ZIP/Postal Code
3015 GD
Country
Netherlands
Facility Name
Galderma Investigational Site 6027
City
Utrecht
ZIP/Postal Code
3584 CX
Country
Netherlands
Facility Name
Galderma Investigational Site 6119
City
Hamilton
ZIP/Postal Code
3204
Country
New Zealand
Facility Name
Galderma Investigational Site 6118
City
Wellington
ZIP/Postal Code
6021
Country
New Zealand
Facility Name
Galderma Investigational Site 5773
City
Białystok
ZIP/Postal Code
15-453
Country
Poland
Facility Name
Galderma Investigational Site 6097
City
Chorzów
ZIP/Postal Code
41-500
Country
Poland
Facility Name
Galderma Investigational Site 6255
City
Czestochowa
ZIP/Postal Code
42-202
Country
Poland
Facility Name
Galderma Investigational Site 6075
City
Gdańsk
ZIP/Postal Code
80-214
Country
Poland
Facility Name
Galderma Investigational Site 6243
City
Gdańsk
ZIP/Postal Code
80-382
Country
Poland
Facility Name
Galderma Investigational Site 5138
City
Gdańsk
ZIP/Postal Code
80-803
Country
Poland
Facility Name
Galderma Investigational Site 6244
City
Gdynia
ZIP/Postal Code
81-537
Country
Poland
Facility Name
Galderma Investigational Site 6087
City
Katowice
ZIP/Postal Code
40-040
Country
Poland
Facility Name
Galderma Investigational Site 5021
City
Katowice
ZIP/Postal Code
40-611
Country
Poland
Facility Name
Galderma Investigational Site 5362
City
Kraków
ZIP/Postal Code
30-033
Country
Poland
Facility Name
Galderma Investigational Site 6052
City
Kraków
ZIP/Postal Code
31-559
Country
Poland
Facility Name
Galderma Investigational Site 5367
City
Lublin
ZIP/Postal Code
20-080
Country
Poland
Facility Name
Galderma Investigational Site 6071
City
Lublin
ZIP/Postal Code
20-081
Country
Poland
Facility Name
Galderma Investigational Site 5377
City
Nowa Sól
ZIP/Postal Code
67-100
Country
Poland
Facility Name
Galderma Investigational Site 6063
City
Olsztyn
ZIP/Postal Code
10-229
Country
Poland
Facility Name
Galderma Investigational Site 6237
City
Ostrowiec Świętokrzyski
ZIP/Postal Code
27-400
Country
Poland
Facility Name
Galderma Investigational Site 6085
City
Poznań
ZIP/Postal Code
60-529
Country
Poland
Facility Name
Galderma Investigational Site 6127
City
Poznań
ZIP/Postal Code
60-702
Country
Poland
Facility Name
Galderma Investigational Site 5495
City
Rzeszów
ZIP/Postal Code
35-055
Country
Poland
Facility Name
Galderma Investigational Site 6088
City
Rzeszów
ZIP/Postal Code
35-055
Country
Poland
Facility Name
Galderma Investigational Site 6223
City
Szczecin
ZIP/Postal Code
70-332
Country
Poland
Facility Name
Galderma Investigational Site 6130
City
Szczecin
ZIP/Postal Code
71-434
Country
Poland
Facility Name
Galderma Investigational Site 6048
City
Tarnow
ZIP/Postal Code
33-100
Country
Poland
Facility Name
Galderma Investigational Site 6126
City
Warsaw
ZIP/Postal Code
01-142
Country
Poland
Facility Name
Galderma Investigational Site 5707
City
Warsaw
ZIP/Postal Code
01-817
Country
Poland
Facility Name
Galderma Investigational Site 6065
City
Warszawa
ZIP/Postal Code
01-192
Country
Poland
Facility Name
Galderma Investigational Site 6122
City
Warszawa
ZIP/Postal Code
02-507
Country
Poland
Facility Name
Galderma Investigational Site 6242
City
Warszawa
ZIP/Postal Code
02-793
Country
Poland
Facility Name
Galderma Investigational Site 6064
City
Warszawa
ZIP/Postal Code
02-953
Country
Poland
Facility Name
Galderma Investigational Site 6222
City
Warszawa
ZIP/Postal Code
02-962
Country
Poland
Facility Name
Galderma Investigational Site 6047
City
Wrocław
ZIP/Postal Code
50-381
Country
Poland
Facility Name
Galderma Investigational Site 6185
City
Wrocław
ZIP/Postal Code
50-566
Country
Poland
Facility Name
Galderma Investigational Site 6096
City
Wrocław
ZIP/Postal Code
51-318
Country
Poland
Facility Name
Galderma Investigational Site 5005
City
Wrocław
ZIP/Postal Code
53-658
Country
Poland
Facility Name
Galderma Investigational Site 6245
City
Łódź
ZIP/Postal Code
90-127
Country
Poland
Facility Name
Galderma Investigational Site 5570
City
Łódź
ZIP/Postal Code
90-265
Country
Poland
Facility Name
Galderma Investigational Site 5363
City
Łódź
ZIP/Postal Code
90-436
Country
Poland
Facility Name
Galderma Investigational Site 6231
City
Łódź
ZIP/Postal Code
94-050
Country
Poland
Facility Name
Galderma Investigational Site 6124
City
Singapore
ZIP/Postal Code
119228
Country
Singapore
Facility Name
Galderma Investigational Site 6077
City
Singapore
ZIP/Postal Code
169608
Country
Singapore
Facility Name
Galderma Investigational Site 5499
City
Singapore
ZIP/Postal Code
308205
Country
Singapore
Facility Name
Galderma Investigational Site 6057
City
Alicante
ZIP/Postal Code
03010
Country
Spain
Facility Name
Galderma Investigational Site 6037
City
Barcelona
ZIP/Postal Code
08036
Country
Spain
Facility Name
Galderma Investigational Site 6035
City
Barcelona
ZIP/Postal Code
08916
Country
Spain
Facility Name
Galderma Investigational Site 5580
City
L'Hospitalet De Llobregat
ZIP/Postal Code
08907
Country
Spain
Facility Name
Galderma Investigational Site 6106
City
Las Palmas De Gran Canaria
ZIP/Postal Code
35010
Country
Spain
Facility Name
Galderma Investigational Site 6058
City
Madrid
ZIP/Postal Code
28006
Country
Spain
Facility Name
Galderma Investigational Site 5842
City
Madrid
ZIP/Postal Code
28034
Country
Spain
Facility Name
Galderma Investigational Site 6190
City
Madrid
ZIP/Postal Code
28046
Country
Spain
Facility Name
Galderma Investigational Site 6186
City
Madrid
ZIP/Postal Code
28222
Country
Spain
Facility Name
Galderma Investigational Site 6036
City
Madrid
ZIP/Postal Code
28223
Country
Spain
Facility Name
Galderma Investigational Site 5551
City
Madrid
ZIP/Postal Code
28922
Country
Spain
Facility Name
Galderma Investigational Site 6191
City
Pamplona
ZIP/Postal Code
31008
Country
Spain
Facility Name
Galderma Investigational Site 6202
City
Barnsley
ZIP/Postal Code
S75 3DL
Country
United Kingdom
Facility Name
Galderma Investigational Site 6207
City
Blackpool
ZIP/Postal Code
FY2 0JH
Country
United Kingdom
Facility Name
Galderma Investigational Site 6203
City
Cannock
ZIP/Postal Code
WS11 0BN
Country
United Kingdom
Facility Name
Galderma Investigational Site 6090
City
Dudley
ZIP/Postal Code
DY1 2HQ
Country
United Kingdom
Facility Name
Galderma Investigational Site 6104
City
Glasgow
ZIP/Postal Code
G3 8SJ
Country
United Kingdom
Facility Name
Galderma Investigational Site 6204
City
Liverpool
ZIP/Postal Code
L34 1BH
Country
United Kingdom
Facility Name
Galderma Investigational Site 6121
City
London
ZIP/Postal Code
SE1 9RT
Country
United Kingdom
Facility Name
Galderma Investigational Site 6205
City
Manchester
ZIP/Postal Code
M13 9NQ
Country
United Kingdom
Facility Name
Galderma Investigational Site 6208
City
Newcastle
ZIP/Postal Code
NE1 4LP
Country
United Kingdom
Facility Name
Galderma Investigational Site 6206
City
Stockton-on-Tees
ZIP/Postal Code
TS17 6EW
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

We'll reach out to this number within 24 hrs